Comparison of Mortality and Morbidity of Robotic Versus Laparoscopic Radical Nephrectomy for the Treatment of Renal Cell Carcinoma—An Analysis of the National Surgery Quality Improvement Program (NSQIP) Targeted Nephrectomy Database

We found no significant difference in the major complications between RARN and LRN for patients undergoing radical nephrectomy. At the expense of a somewhat longer operative time, RARN was associated with a lower risk of SSI and a lower conversion rate to open RN. LRN and RARN should both be considered and selected on an individualized basis using tumor, patient, and physician factors.

Authors

Institutions

Publication Details

Journal
Current Oncology
Published
2025-06-17
DOI
https://doi.org/10.3390/curroncol32060358
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of Mortality and Morbidity of Robotic Versus Laparoscopic Radical Nephrectomy for the Treatment of Renal Cell Carcinoma—An Analysis of the National Surgery Quality Improvement Program (NSQIP) Targeted Nephrectomy Database

Jiaqiong Xu, Emily Huang, Dharam Kaushik, Renil S. Titus et al.
Current Oncology
Renal cell carcinoma treatment
article

Comparison of Mortality and Morbidity of Robotic Versus Laparoscopic Radical Nephrectomy for the Treatment of Renal Cell Carcinoma—An Analysis of the National Surgery Quality Improvement Program (NSQIP) Targeted Nephrectomy Database

Jiaqiong Xu, Emily Huang, Dharam Kaushik, Renil S. Titus, Brian J. Miles, Carlos Riveros, Sanjana Ranganathan, Vatsala Mundra, Christopher J. D. Wallis, Zachary Melchiode, Siqi Hu, Raj Satkunasivam, Eusebio Luna-Velazquez
article en

Abstract

We found no significant difference in the major complications between RARN and LRN for patients undergoing radical nephrectomy. At the expense of a somewhat longer operative time, RARN was associated with a lower risk of SSI and a lower conversion rate to open RN. LRN and RARN should both be considered and selected on an individualized basis using tumor, patient, and physician factors.

Current OncologyVol. 32(6)
Mount Sinai Hospital (CA), Houston Methodist (US), University Health Network (CA), University of Toronto (CA), Princess Margaret Cancer Centre (CA), Methodist Hospital (US)
Openalex Percentile: Top 77%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.